HempTalk News and Blog

The hemp-infused beverage sector has emerged as one of the fastest-growing segments within the broader cannabis industry. Driven by a significant shift in consumer preference toward alternative consumption methods, these products offer a smokeless, d...

This week’s plant medicine newsletter covers CBD’s potential for neuroinflammation and Alzheimer’s disease, new research on CBD for chemotherapy-induced pain, oral health, and acne, plus updates on medical cannabis in the workplace and the DEA’s resc...

This week’s newsletter covers a promising psychedelic therapy pilot study for clinical depression, psilocybin research on dementia and childhood trauma, new findings on CBD for lung cancer and neuropathic pain, and a closer look at why federal mariju...

This week’s newsletter covers CBD’s potential for addressing digital era fatigue, critical perspectives on psychedelic research and clinical overreach, the case for whole-mushroom psilocybin studies, and new insights into the endocannabinoid system’s...

This week’s newsletter covers CBD’s potential to reduce Alzheimer’s-related brain inflammation, psilocybin’s promise for pain relief and neurological conditions, cannabis as an alternative to opioids for chronic pain, and critical perspectives on AI ...

This week’s newsletter covers new research on how cannabis affects brain activity during sleep, promising findings on CBD’s role in pain management and Alzheimer’s disease, a clinical trial on cannabis oil for fibromyalgia, and a roundup of notable c...